PT
Pierogi Therapeutics, Inc
SEC filingBiotechnology · Pittsburgh, PA
Amount raised$50Ksold at filing
Total offering$4M$4M still open
Investors in the raise1count reported to the SEC
FiledJun 17, 2026first sale Jun 9, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Filipp Benjamin GusevExecutive Officer, Director
Samuel Benjamin KobyExecutive Officer, Director
Executive officers, directors and promoters as listed on the Form D.